Skip to main content
Livermore
Livermore
ZHEN

Front Row Advisors LLC

SEC CIK
0001729254
Latest filing
Aug 13, 2026

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by Front Row Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings

Shares (Q2 2026)
7
Value
$1.55K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of ALNY by Front Row Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20267$1.55K<0.1%00.0%UnchangedHolders
Q1 20267$2.32K<0.1%00.0%UnchangedHolders
Q4 20257$2.78K<0.1%00.0%UnchangedHolders
Q3 20257$3.19K<0.1%−2−22.2%ReducedHolders
Q2 20259$2.94K<0.1%−5−35.7%ReducedHolders
Q1 202514$3.78K<0.1%00.0%UnchangedHolders
Q4 202414$3.29K<0.1%00.0%UnchangedHolders
Q3 202414$3.85K<0.1%00.0%UnchangedHolders
Q2 202414$3.40K<0.1%00.0%UnchangedHolders
Q1 202414$2.09K<0.1%00.0%UnchangedHolders
Q4 202314$2.68K<0.1%00.0%UnchangedHolders
Q3 202314$2.48K<0.1%00.0%UnchangedHolders
Q2 202314$3.00K<0.1%00.0%UnchangedHolders
Q1 202314$3.00K<0.1%+14NewHolders
Q4 20220$00.0%−14−100.0%Sold outHolders
Q3 202214$3.00K<0.1%00.0%UnchangedHolders
Q2 202214$2.00K<0.1%00.0%UnchangedHolders
Q1 202214$2.00K<0.1%00.0%UnchangedHolders
Q4 202114$2.00K<0.1%00.0%UnchangedHolders
Q3 202114$3.00K<0.1%00.0%UnchangedHolders
Q2 202114$3.00K<0.1%00.0%UnchangedHolders
Q1 202114$2.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.